You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

HIPREX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Hiprex, and when can generic versions of Hiprex launch?

Hiprex is a drug marketed by Ss Pharma and is included in one NDA.

The generic ingredient in HIPREX is methenamine hippurate. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the methenamine hippurate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Hiprex

A generic version of HIPREX was approved as methenamine hippurate by AUROBINDO PHARMA LTD on July 5th, 2016.

  Try a Trial

Drug patent expirations by year for HIPREX
Drug Prices for HIPREX

See drug prices for HIPREX

Recent Clinical Trials for HIPREX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Texas Southwestern Medical CenterPhase 4
University of PennsylvaniaN/A

See all HIPREX clinical trials

US Patents and Regulatory Information for HIPREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ss Pharma HIPREX methenamine hippurate TABLET;ORAL 017681-001 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.